| RYANX | RYVYX | RYANX / RYVYX | |
| Total Expense Ratio | 1.57 | 1.74 | 90% |
| Annual Report Gross Expense Ratio | 1.63 | 1.87 | 87% |
| Fund Existence | 22 years | 26 years | - |
| Gain YTD | 12.364 | 18.431 | 67% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 249M | 1.59B | 16% |
| Annual Yield % from dividends | 0.76 | 0.00 | - |
| Returns for 1 year | 24.58 | 26.31 | 93% |
| Returns for 3 years | 90.16 | 112.92 | 80% |
| Returns for 5 years | 39.40 | 81.53 | 48% |
| Returns for 10 years | 266.60 | 882.52 | 30% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FEIFX | 37.47 | 0.23 | +0.62% |
| Franklin Equity Income Adv | |||
| JSJCX | 15.12 | 0.03 | +0.20% |
| JHancock Small Cap Dynamic Growth C | |||
| VIMAX | 400.89 | -0.30 | -0.07% |
| Vanguard Morn Mid Cap Index Admiral | |||
| VSFSX | 29.75 | -0.10 | -0.34% |
| Federated Hermes MDT Small Cap Value R6 | |||
| PHLCX | 10.41 | -0.12 | -1.14% |
| PGIM Jennison Health Sciences C | |||